INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1256602998-psychedelic-mindfulness]( "The Renaissance Of Psychedelic Research: History, Protocols, And Forward Trajectories")
The Renaissance Of Psychedelic Research: History, Protocols, And Forward TrajectoriesDiscover how clinical trial protocols are evolving to address unblinding, therapeutic support variables, and regulatory standards in modern psychedelic research.
-
![Clinical Leader Solutions Expo]( "Running Flexible Trials In The Heart Of Patient Communities")
Running Flexible Trials In The Heart Of Patient CommunitiesBringing clinical research closer to patients by running flexible trials in the heart of their own communities increases access to research for both patients and sites.
-
![Cut Corners increase speed]( "Cutting Corners In RTSM Software Increases Speed...And RISK!")
Cutting Corners In RTSM Software Increases Speed...And RISK!Discover why true RTSM efficiency requires rigor, not shortcuts — highlighting how thoughtful processes and clear communication deliver speed without compromising quality or introducing avoidable risk.
-
![Protocol Flexibility Is A Quality Strategy]( "Protocol Flexibility Is A Quality Strategy")
Protocol Flexibility Is A Quality StrategyAnna-Zeralda Canals Hamann shares how flexible IRT design can help sponsors prepare for changes in supply strategy, dosing, and patient cohorts. Effective RTSM systems are designed to manage uncertainty without disrupting trial operations.
-
At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense12/23/2025
At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.
-
Reducing The Travel Burden For Patients - The Benefits Of Mobile Vision Clinics3/11/2025
Travel to trial sites can be a major hurdle for patients considering participation, but mobile vision clinics are providing a solution to improve accessibility, capacity, and patient enrollment.
-
The Impact Of Expert PK/PD Modeling In Psychedelic Research12/2/2025
Model-informed development that integrates preclinical and literature-based data is enabling smarter predictions of exposure and safety, transforming psychedelic research and advancing clinical innovation.
-
Strategic CMC Considerations For Pre-IND Meetings: Setting The Stage For A Successful TPP9/1/2025
In biotechnology, the Pre-Investigational New Drug (Pre-IND) stage is a critical juncture. Explore the pivotal role of Chemistry, Manufacturing, and Controls (CMC) in navigating this phase.
-
Evolution Of ERP In Biotech And Integration Challenges10/22/2024
Consolidating various software systems enables efficient management of direct fees, pass-throughs, and investigator grants within a single platform, providing a complete view of your trials' financial health.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-639668490 patient]( "Scout: Beyond The Numbers")
Patient retention has benefits beyond what’s reflected in a data set. Explore some of the ways clinical trial participation can have a transformative impact on patients and their families.
-
![Patient Satisfaction survey-GettyImages-1356228571]( "Elevating Success: The Crucial Role Of Customer Satisfaction Programs In Companies")
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
-
![Data analysis science and big data with AI technology-GettyImages-1979289147]( "Data Lifecycle At CRC")
A structured data lifecycle from protocol design to database lock keeps trial data clean, compliant, and ready for regulatory submission.
-
![GettyImages-1414481878 clinical trial, patient, diversity]( "Supporting Sites And Patients With People-First Solutions")
Discover how Scout supports patient retention with people-first solutions for reimbursement and travel at no cost to sites.
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "Integrated Programs To Bridge Molecules From Discovery Into Clinical Development")
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
